These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 7536100)

  • 21. Renal and haemodynamic effects of nitric oxide blockade in a Wistar assay rat during high pressure cross-circulation of an isolated denervated kidney.
    Bergström G; Rudenstam J; Creutz J; Göthberg G; Karlström G
    Acta Physiol Scand; 1995 Jun; 154(2):241-52. PubMed ID: 7572220
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the effects of aminoguanidine and N omega-nitro-L-arginine methyl ester on the multiple organ dysfunction caused by endotoxaemia in the rat.
    Wu CC; Ruetten H; Thiemermann C
    Eur J Pharmacol; 1996 Apr; 300(1-2):99-104. PubMed ID: 8741172
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ramipril prevents the detrimental sequels of chronic NO synthase inhibition in rats: hypertension, cardiac hypertrophy and renal insufficiency.
    Hropot M; Grötsch H; Klaus E; Langer KH; Linz W; Wiemer G; Schölkens BA
    Naunyn Schmiedebergs Arch Pharmacol; 1994 Dec; 350(6):646-52. PubMed ID: 7535899
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Localization and regulation of endothelial NO synthase mRNA expression in rat kidney.
    Ujiie K; Yuen J; Hogarth L; Danziger R; Star RA
    Am J Physiol; 1994 Aug; 267(2 Pt 2):F296-302. PubMed ID: 7520668
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of calcium-dependent nitric oxide synthase causes ileitis and leukocytosis in guinea pigs.
    Miller MJ; Munshi UK; Sadowska-Krowicka H; Kakkis JL; Zhang XJ; Eloby-Childress S; Clark DA
    Dig Dis Sci; 1994 Jun; 39(6):1185-92. PubMed ID: 7515342
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Administration of nitric oxide synthase inhibitors in experimental autoimmune neuritis and experimental autoimmune encephalomyelitis.
    Zielasek J; Jung S; Gold R; Liew FY; Toyka KV; Hartung HP
    J Neuroimmunol; 1995 Apr; 58(1):81-8. PubMed ID: 7537283
    [TBL] [Abstract][Full Text] [Related]  

  • 27. VIP enhances and nitric oxide synthase inhibitor reduces survival of rat lungs perfused ex vivo.
    Pakbaz H; Berisha H; Sharaf H; Foda HD; Said SI
    Ann N Y Acad Sci; 1994 Jun; 723():426-8. PubMed ID: 7518202
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The involvement of nitric oxide in the ovulatory process in the rat.
    Shukovski L; Tsafriri A
    Endocrinology; 1994 Nov; 135(5):2287-90. PubMed ID: 7525265
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Renal disposition and effects of naproxen and its l-enantiomer in the isolated perfused rat kidney.
    Cox PG; Moons WM; Russel FG; van Ginneken CA
    J Pharmacol Exp Ther; 1990 Nov; 255(2):491-6. PubMed ID: 2243339
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mediators of the direct effects of amino acids on the rat kidney.
    el Sayed AA; Haylor J; el Nahas AM
    Clin Sci (Lond); 1991 Sep; 81(3):427-32. PubMed ID: 1680595
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence that insulin-like growth factor I increases renal plasma flow and glomerular filtration rate in fasted rats.
    Hirschberg R; Kopple JD
    J Clin Invest; 1989 Jan; 83(1):326-30. PubMed ID: 2910916
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of insulin-like growth factor I on renal function in normal men.
    Hirschberg R; Brunori G; Kopple JD; Guler HP
    Kidney Int; 1993 Feb; 43(2):387-97. PubMed ID: 8441234
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nitric oxide synthesis inhibitor prevents vasodilation by insulin-like growth factor I.
    Haylor J; Singh I; el Nahas AM
    Kidney Int; 1991 Feb; 39(2):333-5. PubMed ID: 2002647
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of IGF-I on renal function in patients with chronic renal failure.
    O'Shea MH; Miller SB; Hammerman MR
    Am J Physiol; 1993 May; 264(5 Pt 2):F917-22. PubMed ID: 8498545
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of bis(p-chlorophenyl) acetic acid on the renal function of the rat.
    Koschier FJ; Gigliotti PJ; Hong SK
    J Environ Pathol Toxicol; 1980 Nov; 4(5-6):209-17. PubMed ID: 7217846
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of diatrizoate on the function of the isolated perfused rat kidney.
    Brown P; Haylor J; Morcos SK; Cope GH; el Nahas AM
    Br J Radiol; 1992 Nov; 65(779):1011-7. PubMed ID: 1450815
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decreased renin release and constant kallikrein secretion after injection of L-NAME in isolated perfused rat kidney.
    Gardes J; Poux JM; Gonzalez MF; Alhenc-Gelas F; Menard J
    Life Sci; 1992; 50(14):987-93. PubMed ID: 1552826
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulin-like growth factor I produces renal hyperfiltration by a kinin-mediated mechanism.
    Jaffa AA; LeRoith D; Roberts CT; Rust PF; Mayfield RK
    Am J Physiol; 1994 Jan; 266(1 Pt 2):F102-7. PubMed ID: 8304475
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The mechanism of renal hyperperfusion induced by hyperglycemia].
    Qi ZH; Li SY; Hao CM
    Zhonghua Yi Xue Za Zhi; 1994 Jan; 74(1):5-8, 61. PubMed ID: 8032986
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The growth hormone-insulin-like growth factor I axis and renal glomerular function.
    Hirschberg R; Kopple JD
    J Am Soc Nephrol; 1992 Mar; 2(9):1417-22. PubMed ID: 1385734
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.